-
Assessing Stakeholder Perceptions of Product Portfolio Value Beyond Financial Benefit: Development of a Survey
Mar 10, 2025, 14:00 PM -
Updated 1-Year Fracture Incidence and Costs of Fragility Fractures in US Post-Fracture Patients Based on Commercial Claims Databases
Mar 10, 2025, 14:00 PM -
Real-World Telehealth Utilization and Healthcare Costs in Commercially Insured Women With Breast Cancer: A Claims-Based Study
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Associated Costs in Patients With Transthyretin Cardiac Amyloidosis and Non-amyloid Heart Failure
Mar 10, 2025, 14:00 PM -
Empowering Healthcare Decision-Making: Leveraging Standardized Template for Enhanced Reliability and Efficiency in Budget Impact Analysis by Health Technology Assessment Agency
Mar 10, 2025, 14:00 PM -
Trends in Breast Cancer Drugs Approved by the US Food and Drug Administration, 1980-2024
Mar 10, 2025, 14:00 PM -
An Economic Model to Estimate Costs of Adverse Events in Patients Treated With Lisocabtagene Maraleucel (liso-cel), Axicabtagene Ciloleucel (axi-cel), or Tisagenlecleucel (tisa-cel) for Relapsed/Refractory Follicular Lymphoma
Mar 10, 2025, 14:00 PM -
K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)
Mar 10, 2025, 14:00 PM -
Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fractures In Neurologically Intact Patients: A Cost-Utility Analysis
Mar 10, 2025, 14:00 PM -
Treatment Patterns in the Management of Multiple Myeloma in a Colombian HMO During 2015–2023: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Long-Term Cost-Effectiveness Analysis of Once-Weekly Insulin Icodec Versus Once-Daily Basal Insulin Analogues in Patients With Type 2 Diabetes in China
Mar 10, 2025, 14:00 PM -
Modeling the Path to Cure: How (NEO)Adjuvant Drug Therapies are Evaluated in Health Technology Assessment (HTA)
Mar 10, 2025, 14:00 PM -
Racial and Health Insurance Status Disparities in the Use of Percutaneous Vertebral Augmentation and Healthcare Utilization for Osteoporotic Vertebral Fractures: A Retrospective Observational Analysis
Mar 10, 2025, 14:00 PM -
Study on Online Tools of Pharmacoeconomic Model Construction and Value Communication
Mar 10, 2025, 14:00 PM -
Ferric Derisomaltose for the Treatment of Iron Deficiency Anemia: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Assessment of Artificial Intelligence-Enabled Health Technologies: Our Initial Experience at Canada's Drug Agency
Mar 10, 2025, 14:00 PM -
The Utility of Adaptive Design Clinical Trials for Vaccines
Mar 10, 2025, 14:00 PM -
Dupilumab Improves Health-Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: Results From the BOREAS and NOTUS Trials
Mar 10, 2025, 14:00 PM -
Comorbidity Burden Among Patients with Bullous Pemphigoid in the US Medicare Population
Mar 10, 2025, 14:00 PM -
Imputing Breast Cancer Stage in a Large EHR Dataset: Light Gradient Boosting Machine Algorithm and Explainable Artificial Intelligence
Mar 10, 2025, 14:00 PM